Search results for "Cognition disorders"

showing 10 items of 277 documents

Co-occurrence of developmental delays in a screening study of 4-year-old Finnish children

2004

The aim of this population study was to examine the severity and prevalence of co-occurring developmental delays in 4-year-old children, the rate of overlapping problems, and sex differences. A sample of 434 children (196 males, 238 females; mean age 4 years 3 months, SD 1 month) were administered the 'Lene' test: a comprehensive neurodevelopmental screening test. Results suggest that co-occurrence of attention-behavioural, motor-perceptual, and language delays occurring in school-aged children could already be detected at the age of 4 years. Isolated delays were usually mild, but co-occurring difficulties were mostly moderate or severe. Overlap between developmental delays depended on the …

MalePediatricsmedicine.medical_specialtyScreening testDevelopmental DisabilitiesComorbiditySpeech DisordersCohort StudiesCatchment Area HealthDevelopmental NeurosciencemedicineHumansMass ScreeningRisk factorChildFinlandScreening studyLanguage DisordersCo-occurrenceMean agemedicine.diseaseComorbidityMotor Skills DisordersChild PreschoolPediatrics Perinatology and Child HealthPopulation studyFemaleNeurology (clinical)Cognition DisordersFactor Analysis StatisticalPsychologyCohort studyDevelopmental Medicine & Child Neurology
researchProduct

Cognitive-behavioral screening in elderly patients with new-onset epilepsy before treatment

2014

Objectives Cognitive comorbidity at epilepsy onset reflects disease severity and provides a baseline estimate of reserve capacities with regard to the effects of epilepsy and its treatment. Given the high incidence of epilepsy at an older age, this study analyzed objective and subjective cognition as well as quality of life in elderly patients with new-onset focal epilepsy before initiation of anti-epileptic treatment. Materials and methods A total of 257 untreated patients (60–95 years of age) with new-onset epilepsy underwent objective assessment of executive function (EpiTrack) and performed subjective ratings of cognition (Portland Neurotoxicity Scale) and quality of life (QoL; QOLIE-31…

MalePediatricsmedicine.medical_specialtymedia_common.quotation_subjectComorbidityExecutive FunctionEpilepsyDouble-Blind MethodmedicineHumansAgedmedia_commonAged 80 and overEpilepsyIncidenceNeuropsychologyCognitionGeneral MedicineMiddle AgedExecutive functionsmedicine.diseaseComorbidityNeurologyQuality of LifeEtiologyPhysical therapyAnticonvulsantsFemaleNeurology (clinical)Cognition DisordersPsychologyBody mass indexVigilance (psychology)Acta Neurologica Scandinavica
researchProduct

Systolic Blood Pressure Variation and Mean Heart Rate Is Associated With Cognitive Dysfunction in Patients With High Cardiovascular Risk

2015

Abstract— Elevated systolic blood pressure (SBP) correlates to cognitive decline and incident dementia. The effects of heart rate (HR), visit to visit HR variation, and visit to visit SBP variation are less well established. Patients without preexisting cognitive dysfunction (N=24 593) were evaluated according to mean SBP, SBP visit to visit variation (coefficient of variation [standard deviation/mean×100%], CV), mean HR, and visit to visit HR variation (HR-CV) in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease. Cognitive function was assessed with min…

MalePredictive Value of TestAngiotensin-Converting Enzyme InhibitorsBlood PressureBenzimidazoleBenzoatesRamiprilRetrospective StudieHeart RateRisk FactorsCardiovascular DiseaseTelmisartanCognitive declineMultivariate AnalysiRandomized Controlled Trials as TopicAged 80 and overmedicine.diagnostic_testIncidenceMiddle AgedstrokeAntihypertensive Agentmyocardial infarctionCardiovascular DiseasesHypertensionCardiologyDrug Therapy CombinationFemaleHumanmedicine.drugRamiprilmedicine.medical_specialtyBenzoateFollow-Up StudieCognition DisorderPredictive Value of TestsInternal medicineHeart rateInternal MedicinemedicineHumansDementiaAntihypertensive AgentsAgedRetrospective StudiesMini–Mental State Examinationbusiness.industryRisk FactorAngiotensin-Converting Enzyme InhibitorOdds ratiomedicine.diseaseConfidence intervalBlood pressureMultivariate AnalysisPhysical therapyBenzimidazolesCognition DisordersbusinessFollow-Up StudiesHypertension
researchProduct

Isolated, subtle, neurological abnormalities in neurologically and cognitively healthy aging subjects

2015

The aim of this study is to describe the frequency of isolated, subtle, neurological abnormalities (ISNAs) in a large population of neurologically and cognitively healthy subjects and to compare ISNAs to various types of MRI-detected cerebrovascular lesions and subcortical brain atrophy in different age classes. 907 subjects were selected from a large, prospective hospital-based study. At baseline neurological examination, 17 ISNAs were selected. Primitive reflexes were the most common ISNAs (35.8 %), while dysphagia was the most rarely encountered (0.3 %). Measures of small vessel disease, i.e., deep and subcortical white matter hyperintensity and lacunar infarcts as well as subcortical at…

MalePrimitive reflexesAgingmedicine.medical_specialtyPathologyNeurologyNeurological examinationNeuropsychological TestsCarotid Intima-Media ThicknessAge DistributionApolipoproteins EAtrophyInternal medicinemedicineHumansAgedUltrasonographyNeuroradiologyAged 80 and overNeurologic ExaminationISNAs White matter hyperintensity Lacunae Subcortical atrophymedicine.diagnostic_testMyocardiumSettore MED/37 - NeuroradiologiaMagnetic resonance imagingMiddle Agedmedicine.diseaseMagnetic Resonance ImagingDysphagiaHyperintensityLogistic ModelsNeurologyCardiologyFemaleSettore MED/26 - NeurologiaNeurology (clinical)Nervous System Diseasesmedicine.symptomCognition DisordersSettore MED/36 - Diagnostica Per Immagini E RadioterapiaPsychologyJournal of Neurology
researchProduct

Cognitive estimation: Performance of patients with focal frontal and posterior lesions

2018

The Cognitive Estimation Test (CET) is a widely used test to investigate estimation abilities requiring complex processes such as reasoning, the development and application of appropriate strategies, response plausibility checking as well as general knowledge and numeracy (e.g., Shallice and Evans, 1978; MacPherson et al., 2014). Thus far, it remains unknown whether the CET is both sensitive and specific to frontal lobe dysfunction. Neuroimaging techniques may not represent a useful methodology for answering this question since the complex processes involved are likely to be associated with a large network of brain regions, some of which are not functionally necessary to successfully carry …

MaleRAPM Raven's Advanced Progressive MatricesNo NumberNeuropsychological TestsAudiologyPrefrontal cortexBrain mappingDevelopmental psychologyCVA cerebrovascular accidentExecutive functionsBehavioral NeurosciencePFC prefrontal cortex0302 clinical medicineBrain Injuries TraumaticImage Processing Computer-AssistedPrefrontal cortexprefrontal cortexBrain Mapping05 social sciencesGNT Graded Naming TestNeuropsychologyCognitionMiddle Agedexecutive functionsExecutive functionsMagnetic Resonance ImagingFrontal Lobefluid IntelligenceFrontal lobeFemaleAnalysis of varianceFluid intelligencePsychologyAdultmedicine.medical_specialtyCognitive NeuroscienceExperimental and Cognitive PsychologyCognitive estimation testCognitive Estimation TestArticle050105 experimental psychology03 medical and health sciencesNeuroimagingmedicineHumans0501 psychology and cognitive sciencesAgedAnalysis of VarianceHC healthy comparisonsIQ Intelligence QuotientCognition DisordersNART National Adult Reading Test030217 neurology & neurosurgeryLF left frontalNeuropsychologia
researchProduct

Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study

2015

Abstract Background It is well known that atrial fibrillation (AF) and chronic kidney disease (CKD) are associated with a higher risk of stroke, and new evidence links AF to cognitive impairment, independently from an overt stroke (CI). Our aim was to investigate, assuming an underlying role of atrial microembolism, the impact of CI and CKD in elderly hospitalized patients with AF. Methods We retrospectively analyzed the data collected on elderly patients in 66 Italian hospitals, in the frame of the REPOSI project. We analyzed the clinical characteristics of patients with AF and different degrees of CI. Multivariate logistic analysis was used to explore the relationship between variables an…

MaleSettore MED/09 - Medicina InternaREPOSI studyKidneyDisability EvaluationRetrospective StudieRisk Factorshospitalized patientAtrial Fibrillation80 and overOdds RatioLS4_4Renal InsufficiencyChronicMultivariate AnalysiStrokeAged 80 and overMedicine (all)BrainAtrial fibrillationStrokeFemaleatrial microembolismHumanGlomerular Filtration Ratemedicine.medical_specialtySocio-culturaleRenal functionelderlyCognition DisorderInternal medicineThromboembolismmedicineInternal MedicineHumansRenal insufficiency chronicHeart AtriaIntensive care medicineAged; Anticoagulants; Atrial fibrillation; Dementia; Renal insufficiency chronic; Stroke; Aged; Aged 80 and over; Anticoagulants; Atrial Fibrillation; Brain; Cognition Disorders; Dementia; Disability Evaluation; Female; Glomerular Filtration Rate; Heart Atria; Humans; Kidney; Male; Multivariate Analysis; Odds Ratio; Renal Insufficiency Chronic; Retrospective Studies; Risk Factors; Stroke; ThromboembolismAgedRetrospective Studiesbusiness.industryRisk FactorSettore MED/09 - MEDICINA INTERNAAnticoagulantAnticoagulantsRetrospective cohort studyOdds ratiomedicine.diseaseAtrial fibrillationBlood pressureHeart failureMultivariate AnalysisAged Anticoagulants Atrial fibrillation Dementia Renal insufficiency chronic Stroke.Aged; Anticoagulants; Atrial fibrillation; Dementia; Renal insufficiency chronic; Strokeatrial microembolism; elderly; hospitalized patients; REPOSI study;DementiabusinessCognition DisordersKidney diseaseAged; Anticoagulants; Atrial fibrillation; Dementia; Renal insufficiency chronic; Stroke; Aged; Aged 80 and over; Anticoagulants; Atrial Fibrillation; Brain; Cognition Disorders; Dementia; Disability Evaluation; Female; Glomerular Filtration Rate; Heart Atria; Humans; Kidney; Male; Multivariate Analysis; Odds Ratio; Renal Insufficiency Chronic; Retrospective Studies; Risk Factors; Stroke; Thromboembolism; Internal Medicine; Medicine (all)
researchProduct

The effects of transdermal rotigotine on non-motor symptoms of Parkinson's disease: a multicentre, observational, retrospective, post-marketing study

2017

This study evaluated the effect of ≥6 months of transdermal rotigotine on non-motor and motor symptoms of patients with advanced Parkinson's disease.The study was conducted in Spain between September 2011 and December 2012 (ClinicalTrials.gov: NCT01504529). The primary efficacy variable was the change from baseline in non-motor symptoms, as assessed by changes in Parkinson's Disease Non-Motor Symptoms Questionnaire total scores at 6 months. Secondary endpoints included the assessment of motor symptoms by Unified Parkinson's Disease Rating Scale III scores.Data from 378 patients (mean age: 70.2 years; 56.9% male) with Parkinson's disease receiving rotigotine from were collected. Mean disease…

MaleSleep Wake Disordersmedicine.medical_specialtyParkinson's diseaseTetrahydronaphthalenesThiophenesDiseaseAdministration CutaneousMotor symptoms03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesProduct Surveillance PostmarketingmedicineHumans030212 general & internal medicineAgedRetrospective StudiesTransdermalAged 80 and overbusiness.industryGeneral NeuroscienceParkinson DiseaseRotigotineGeneral MedicineUrination Disordersmedicine.diseaseClinical PracticeTreatment OutcomeSpainDopamine AgonistsPhysical therapyNon motorFemaleObservational studyCognition Disordersbusiness030217 neurology & neurosurgerymedicine.drugInternational Journal of Neuroscience
researchProduct

Symbolic function explored in children with epilepsy and headache.

2007

Introduzione. L’attacco alla capacità di pensare è uno dei possibili effetti che possiamo osservare quando il corpo si ammala. Lo scopo di questo studio è esplorare la funzione simbolica in bambini con epilessia e cefalea. Metodi. Sono stati reclutati 75 piccoli pazienti della Clinica Neuropsichiatrica infantile dell’Università di Palermo - 48 maschi (61%) e 27 femmine (39%). Tutti soffrivano di epilessia (53 - 71%) e cefalea primaria (22 - 29%). La loro età variava dai 7 agli 11 anni (media: 9.4±1.2). È stato reclutato anche un gruppo di controllo composto da soggetti che non avevano mai sofferto di malattie croniche o neurologiche. Tale gruppo era pareggiato con il gruppo di pazienti per …

MaleSymbolismEpilepsyepilepsy headache defense mechanisms symbolic function simbolisation mentalizationHeadacheHumansFemaleNeuropsychological TestsChildCognition DisordersSeverity of Illness IndexMinerva pediatrica
researchProduct

Working memory, intelligence and knowledge base in adult persons with intellectual disability

2002

Abstract Previous studies have suggested that performance in working memory (WM) tasks is deficient in all etiologies and at all levels of intellectual disability (ID). Knowledge about WM structure, cognitive processes reflected in WM tasks, or the long-term memory contribution to WM capacity in ID is, however, not satisfactory. In the present study, WM capacity, WM task requirements, as well as effects between WM, skills, knowledge base, and intelligence were explored in two groups with matched fluid intelligence: adult persons with ID and normally developing children aged 3–6 years. The ID Group performed equally well as the children in WM tasks based on familiar semantic information and …

MaleWorking memoryLong-term memoryMemoriaSpatial abilityIntelligenceCognitionMiddle AgedNeuropsychological Testsmedicine.diseaseDevelopmental psychologyClinical PsychologyMemoryIntellectual DisabilityIntellectual disabilityDevelopmental and Educational PsychologyCognitive developmentmedicineMemory spanHumansFemaleCognition DisordersPsychologyFollow-Up StudiesCognitive psychologyResearch in Developmental Disabilities
researchProduct

Xenon improves long-term cognitive function, reduces neuronal loss and chronic neuroinflammation, and improves survival after traumatic brain injury …

2019

Background.Xenon is a noble gas with neuroprotective properties. We previously showed that xenon improves short and long-term outcomes in young adult mice after controlled cortical impact (CCI). This is a follow-up study investigating xenon’s effect on very long-term outcome and survival. Methods.C57BL/6N (n=72) young adult male mice received single CCI or sham surgery and were treated with either xenon (75%Xe:25%O2) or control gas (75% N2:25%O2). The outcomes used were: 1) 24-hour lesion volume and neurological outcome score; 2)contextual fear-conditioning at 2 weeks and 20 months; 3) corpus callosum white matter quantification; 4) immunohistological assessment of neuroinflammation and neu…

MaleXenonhippocampusnerve degenerationCorpus callosumBUPRENORPHINEneuroinflammationMice0302 clinical medicineCognition030202 anesthesiologyAnesthesiologyBrain Injuries TraumaticMedicineEPIDEMIOLOGYYoung adultmemory disordersNeuronstraumatic brain injurySham surgeryBrain3. Good healthD-ASPARTATE RECEPTORmedicine.anatomical_structureNeuroprotective AgentsAnesthesianeuroprotectionmedicine.symptomLife Sciences & BiomedicineTraumatic brain injuryHYPOPITUITARISMNeuroprotectionWhite matter03 medical and health sciencesANALGESIAINHALED XENONAnimalsgeneral anaesthesiaSurvival analysisHYPOTHERMIAInflammationScience & Technologybusiness.industry1103 Clinical SciencesHypothermiamedicine.diseaseCOMPETITIVE-INHIBITIONSurvival AnalysisMice Inbred C57BLPATHOLOGYDisease Models AnimalAnesthesiology and Pain MedicineChronic DiseasebusinessCognition Disorders030217 neurology & neurosurgeryWHITE-MATTER DAMAGEFollow-Up StudiesBritish journal of anaesthesia
researchProduct